Galectin Therapeutics (GALT) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GALT is expected to report earnings to rise 16.67% to -20 cents per share on March 27

Galectin Therapeutics GALT Stock Earnings Reports

Q4'24

Est.

$-0.21

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.04

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.06

The last earnings report on November 14 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 382.75K shares outstanding, the current market capitalization sits at 133.06M.

View a ticker or compare two or three

Compare

GALT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GALT
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4960 Peachtree Industrial Boulevard

Phone

+1 678 620-3186

Employees

Web

https://www.galectintherapeutics.com